Afuco™ Anti-Human FLT3 ADCC Therapeutic Antibody (IMC-EB10), ADCC Enhanced
Anti-FLT3 ADCC Enhanced Antibody (IMC-EB10) is an ADCC enhanced antibody produced by our Afuco™ platform. IMC-EB10 is an anti-FLT3 monoclonal antibody, prolongs survival and reduces nonobese diabetic/severe combined immunodeficient engraftment of some acute lymphoblastic leukemia cell lines and primary leukemic samples.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-278CL |
| Pricing | Inquiry |
| Host | Human |
| Target | FLT3 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples. |